Inpharma

Antidepressants in paediatric patients: likelihood of benefit outweighs risk of harm
pp. 1-1(1)

At pains to point out the safety and importance of morphine
pp. 2-2(1)

Universal chickenpox testing cost saving
pp. 3-3(1)

Central stimulant prescribing for ADHD variable in WA
pp. 3-3(1)

Escitalopram cost effective for major depressive disorder
pp. 3-3(1)

US outranks Europe for outpatient antibacterial use
pp. 4-4(1)

Aspirin appears to decrease the risk of Staphylococcus aureus bacteraemia in patients with tunnelled catheters for haemodialysis
pp. 4-4(1)

Dextromethorphan/quinidine eases diabetic neuropathic pain
pp. 4-4(1)

Dapsone gel effective against acne vulgaris
pp. 5-5(1)

Aztreonam beneficial in patients with CF and P. aeruginosa
pp. 5-5(1)

ADX 10059 appears to be effective in the treatment of migraine
pp. 5-5(1)

Ibudilast shows positive results in relapsing MS
pp. 5-5(1)

Oxytocin may improve ability to "infer the affective mental state of others from subtle facial cues"
pp. 6-6(1)

Conjugated linoleic acid reduces body fat and prevents holiday weight gain in overweight individuals
pp. 6-6(1)

Vaginal mucosal vaccine may be effective for recurrent E. coli UTIs
pp. 6-6(1)

Eslicarbazepine fits the bill for refractory partial-onset seizures
pp. 6-6(1)

Pneumococcal 9-valent conjugate vaccine: long-term efficacy
pp. 7-7(1)

Oesophageal cancer: surgery does not enhance chemoradiation
pp. 7-7(1)

The FOLFOX-4 chemotherapy regimen is effective for the treatment of elderly patients with advanced gastric cancer
pp. 7-7(1)

Darbepoetin-α does not affect overall survival in patients with extensive-stage small-cell lung cancer
pp. 7-7(1)

High-dose omeprazole beneficial before endoscopy for GI bleeding
pp. 8-8(1)

Eplerenone is more effective started earlier than later in the treatment of patients with acute myocardial infarction (MI) and heart failure
pp. 8-8(1)

Early cessation of hydroxyprogesterone caproate is associated with an increased risk of recurrent preterm birth
pp. 8-8(1)

Dexamethasone administered prior to spinal anaesthesia can enhance pethidine-induced analgesia and reduce postoperative nausea and vomiting
pp. 8-8(1)

Chromium/biotin effectively reduces the atherogenic index of plasma (AIP) in patients with type 2 diabetes mellitus
pp. 8-8(1)

Everolimus-eluting stent superior: the SPIRIT III trial
pp. 9-10(2)

IM aripiprazole effective for agitation in bipolar I disorders
pp. 10-10(1)

Clindamycin + aminoglycosides vs β-lactams for abdominal infections
pp. 11-11(1)

Adefovir dipivoxil for lamivudine-resistant HBV infections
pp. 11-11(1)

Memantine and gabapentin are effective for the treatment of patients with congenital nystagmus
pp. 11-11(1)

Levosimendan plus dobutamine maintains postoperative stroke volume better than milrinone plus dobutamine among cardiac surgery patients
pp. 11-11(1)

Levetiracetam is effective in the treatment of young children and infants with refractory partial onset seizures
pp. 11-11(1)

Low-dose cytarabine sets the bar for treatment of elderly with AML
pp. 12-12(1)

Aripiprazole, perphenazine for treatment-resistant schizophrenia
pp. 12-12(1)

Chemoembolisation with drug-eluting beads (DEBs) containing doxorubicin is effective in patients with liver cancer
pp. 12-12(1)

Olanzapine and valproic acid are both effective add-on therapies for patients with bipolar disorders experiencing a manic or hypomanic relapse
pp. 12-12(1)

Meropenem monotherapy masters nosocomial infections
pp. 13-14(2)

Ibuprofen is a more effective analgesic than paracetamol or codeine in children presenting with pain due to musculoskeletal trauma
pp. 14-14(1)

Bethanechol chloride is beneficial for patients with severe ineffective oesophageal motility
pp. 14-14(1)

Olanzapine and quetiapine may both be more effective than risperidone in patients with chronic schizophrenia who have discontinued perphenazine
pp. 14-14(1)

Aliskiren plus valsartan a compelling antihypertensive combo
pp. 15-16(2)

Spironolactone sinks resistant hypertension
pp. 16-16(1)

Ramipril, rosiglitazone for atherosclerosis: STARR results?
pp. 17-17(1)

Mycophenolate mofetil may be of greater benefit than azathioprine following heart transplantation
pp. 17-17(1)

Adjunctive montelukast is beneficial in patients with refractory, chronic graft-versus-host disease (GVHD) subsequent to stem cell transplantation
pp. 17-17(1)

Memantine effectively reduces alcohol cue-induced craving for recovering alcohol-dependent patients
pp. 17-17(1)

Positive response to OMV group B meningococcal vax in kids
pp. 18-18(1)

Dexmedetomidine is effective for the treatment of postanaesthesia shivering in children and adolescents
pp. 18-18(1)

Statins have a favourable BP effect: meta-analysis results
pp. 18-18(1)

IV immunoglobulin (IVIg) is effective for the treatment of patients with myasthenia gravis and worsening weakness
pp. 18-18(1)

Dietary supplementation with a cimicifuga [black cohosh] extract reduces the risk of breast cancer
pp. 18-18(1)

The dosing of anidulafungin does not require adjustment in patients with hepatic or renal impairment
pp. 19-19(1)

Food's fine for darunavir
pp. 19-19(1)

Japanese and Caucasian subjects demonstrate comparable duloxetine pharmacokinetics
pp. 19-19(1)

Modest levels of mirtazapine are transferred into breast milk
pp. 19-19(1)

Dorzolamide, in combination with timolol, improves retinal blood flow in patients with juvenile-onset primary open-angle glaucoma
pp. 19-19(1)

Tracheoesophageal fistula reported in Avastin recipients
pp. 20-20(1)

New safety information for epoetin-α, darbepoetin-α
pp. 20-20(1)

NZ Ministry of Health warns of adulterated Chinese medicines
pp. 20-20(1)

A chance gone begging?
pp. 21-21(1)

Aggression/hostility events infrequent with atomoxetine
pp. 21-21(1)

The use of doxycycline to treat children with uncontrolled asthma does not result in tooth staining
pp. 21-21(1)

Nasal desmopressin no longer approved for bedwetting
pp. 22-22(1)

Product approvals in Japan
pp. 22-22(1)

Health Canada warns against herbal sleep supplement
pp. 22-22(1)

The European Commission has granted orphan drug designation to Allos Therapeutics' pralatrexate [PDX] for use in peripheral T-cell lymphoma
pp. 22-22(1)

US product approvals
pp. 23-23(1)